Experts question GAVI’s choice of vaccine

Based on a donation by the Wyeth pharmaceutical company, GAVI recently launched the pneumococcal vaccine, Prevenar, in Rwanda, a first in Africa. Experts question the suitability of the vaccine in the African context, and GAVI’s decision to approve its use.